Shire v. Impax
Jan 01, 2013OUTCOME: Settled
Represented Shire in patent infringement action against Watson and Impax. Hatch Waxman/ para IV ANDA litigation - Intuniv® (guanfacine).
Princeton, NJ
Intellectual property Lawyer at Princeton, NJ
Practice Areas: Intellectual Property, Patent Infringement ... +3 more
OUTCOME: Settled
Represented Shire in patent infringement action against Watson and Impax. Hatch Waxman/ para IV ANDA litigation - Intuniv® (guanfacine).
OUTCOME: One of the patents protecting atorvastatin was invalidated.
Developed grounds for non-infringement and invalidity to support Ranbaxy’s defense in patent infringement action for Lipitor® (atorvastatin) patents following FTF para IV ANDA filing.